Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)

NCT02783729 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1006

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia

Interventions

DRUG: Lemborexant
DRUG: Lemborexant
DRUG: Lemborexant-matched placebo
DRUG: Zolpidem tartrate
DRUG: Zolpidem-matched placebo

Sponsor

Eisai Inc.